Literature DB >> 2026871

Epidermal Langerhans cells are not principal reservoirs of virus in HIV disease.

D C Kalter1, J J Greenhouse, J M Orenstein, S M Schnittman, H E Gendelman, M S Meltzer.   

Abstract

Several reports implicate Langerhans cells of skin as susceptible targets, reservoirs, and vectors for transmission of HIV: 1) numbers of Langerhans cells in skin of HIV-infected patients were decreased about 50% of that in control skin; 2) as many as 30% of Langerhans cells in the skin of HIV-infected patients were morphologically abnormal; 3) viral particles typical for HIV were identified in or around 2 to 5% of these cells; and 4) infectious HIV was isolated from skin biopsies of infected patients. These results were consistent with similar observations of HIV-infected macrophages in such tissues as brain, lung, and lymph node. Despite these findings, other investigators find no evidence for virus infection in the epidermis of HIV-infected patients by any of several immunohistochemical or ultrastructural criteria. To address this controversy, we obtained skin from 28 HIV-seropositive subjects at various clinical stages by full thickness biopsy or suction blister. Samples were analyzed by transmission electron microscopy for presence of HIV virions, by immunofluorescent staining for viral proteins, by in situ hybridization for HIV-specific mRNA, by polymerase chain reaction amplification of virus-specific DNA, and by direct virus isolation by coculture of epidermis onto monocyte target cells. By any of these techniques, demonstration of HIV in the epidermis of infected patients was equivocal and even then, infrequent. In contrast, viral DNA was detected from the dermis of the same skin samples (26 of 28 samples). Moreover, the number and morphology of Langerhans cells in skin of infected patients were within normal limits, regardless of stage of disease. These studies in toto suggest that a role for Langerhans cells as a principal viral reservoir or vector of transmission is highly unlikely.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026871

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.

Authors:  Ari S Nowacek; JoEllyn McMillan; Reagan Miller; Alec Anderson; Barrett Rabinow; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-17       Impact factor: 4.147

Review 2.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

3.  Macrophage endocytic trafficking of antiretroviral nanoparticles.

Authors:  Irena Kadiu; Ari Nowacek; Joellyn McMillan; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2011-03-21       Impact factor: 5.307

Review 4.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

Review 6.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

7.  Epidermal and splenic antigen-presenting cell function in a retrovirally induced murine immunodeficiency syndrome (MAIDS).

Authors:  A Cerny; S Izui; J H Saurat; F A Waldvogel; H C Morse; C Hauser
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Detection of HIV-specific DNA sequences in epidermal Langerhans cells infected in vitro by means of a cell-free system.

Authors:  A S Charbonnier; F Mallet; M M Fiers; C Desgranges; C Dezutter-Dambuyant; D Schmitt
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 9.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

10.  Creation of a long-acting rilpivirine prodrug nanoformulation.

Authors:  James R Hilaire; Aditya N Bade; Brady Sillman; Nagsen Gautam; Jonathan Herskovitz; Bhagya Laxmi Dyavar Shetty; Melinda S Wojtkiewicz; Adam Szlachetka; Benjamin G Lamberty; Sruthi Sravanam; Howard S Fox; Yazen Alnouti; Prasanta K Dash; JoEllyn M McMillan; Benson J Edagwa; Howard E Gendelman
Journal:  J Control Release       Date:  2019-09-03       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.